Global Antibody Drug Conjugates (ADCs) Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 2170 | Number of pages: 193 | Publish Date: Jan 2020 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New

The latest report pertaining to 'Antibody Drug Conjugates (ADCs) Market' provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds.  By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.  ADCs are part of a specialized subset of highly potent APIs.  This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.

Advances in coupling antibodies to cytotoxic drugs permit greater control of drug pharmacokinetics and significantly improve delivery to target tissue. Potent new anti-cancer drugs can now be used to target cancers while minimizing exposure of healthy tissue.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antibody Drug Conjugates (ADCs).

This report studies the global market size of Antibody Drug Conjugates (ADCs), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Antibody Drug Conjugates (ADCs) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
    Roche
    Pfizer
    Novartis
    Genmab
    Bayer
    Seattle Genetics
    Takeda Pharmaceuticals
    AbbVie
    AbGenomics
    ADC Therapeutics
    Astellas Pharma
    Kairos Therapeutics

Market Segment by Product Type
    Seattle Genetics Technology
    ImmunoGen Technology
    Immunomedics Technology

Market Segment by Application
    Hospital
    Clinics
    Others

Antibody Drug Conjugates (ADCs) market report consists of the world’s crucial region market share, size (volume), trends including the product profit, price, value, production, capacity, capability utilization, supply, and demand. Besides, market growth rate, size, and forecasts at the global level have been provided. The geographic areas covered in this report: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from BrandEssenceResearch and presented in this report. 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.



The study objectives are:
    To analyze and research the Antibody Drug Conjugates (ADCs) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Antibody Drug Conjugates (ADCs) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antibody Drug Conjugates (ADCs) are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Antibody Drug Conjugates (ADCs) Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Antibody Drug Conjugates (ADCs) Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Antibody Drug Conjugates (ADCs) Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Antibody Drug Conjugates (ADCs) Market Overview: Quantitative Analysis
3.1. Global Antibody Drug Conjugates (ADCs) Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Antibody Drug Conjugates (ADCs) Market Revenue Market Share (%), 2014- 2025
3.3. Global Antibody Drug Conjugates (ADCs) Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Antibody Drug Conjugates (ADCs) Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Antibody Drug Conjugates (ADCs) Market Analysis: Segmentation By Type
5. Chapter – Global Antibody Drug Conjugates (ADCs) Market Analysis: Segmentation By Application
6. Chapter - Global Antibody Drug Conjugates (ADCs) Market Analysis: By Manufacturer 
6.1. Global Antibody Drug Conjugates (ADCs) Market Revenue (USD Million), by Manufacturer, 2014 - 2025
6.2. Global Antibody Drug Conjugates (ADCs) Market Share (%), by Manufacturer, 2018
6.3. Global Antibody Drug Conjugates (ADCs) Market Sales (Number of Units), by Manufacturer, 2014 - 2025
6.4. Global Antibody Drug Conjugates (ADCs) Market Share (%), by Manufacturer, 2018
6.5. Global Antibody Drug Conjugates (ADCs) Market Price (USD/Unit), by Manufacturer, 2014 - 2025
6.6. Global Antibody Drug Conjugates (ADCs) Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter –Antibody Drug Conjugates (ADCs) Market: Regional Analysis
7.1. North America
7.1.1. North America Antibody Drug Conjugates (ADCs) Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
7.1.2. North America Antibody Drug Conjugates (ADCs) Market Revenue (USD Million) By Country, 2014 – 2025.
7.1.3. North America Antibody Drug Conjugates (ADCs) Revenue Market Share (%) By Country, 2014 – 2025.
7.1.4. North America Antibody Drug Conjugates (ADCs) Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.5. North America Antibody Drug Conjugates (ADCs) Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.6. North America Antibody Drug Conjugates (ADCs) Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
7.1.7. North America Antibody Drug Conjugates (ADCs) Market Sales (Number of Units) By Country, 2014 – 2025.
7.1.8. North America Antibody Drug Conjugates (ADCs) Sales Market Share (%) By Country, 2014 – 2025.
7.1.9. North America Antibody Drug Conjugates (ADCs) Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.10. North America Antibody Drug Conjugates (ADCs) Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.